FIELD: chemistry.
SUBSTANCE: invention relates to improved versions of a method of producing intermediate compounds of formula [5] using a novel compound [1] and to an improved method of producing a compound of formula [13]. Compound of formula [13] exhibits high FLT3 inhibitory activity and can be used as an active ingredient of pharmaceutical products in treating leukaemia. Method of producing a compound of formula [5] , where R1 is C1-6 alkyl group which can be substituted, includes a step for reacting a compound of formula [1] or a salt thereof
with a compound of formula [2] or salt thereof, where R1 has the definition given above, and X1 is a chlorine atom, R2 and R3 are a hydrogen atom or an amino protecting group, or R2 and R3 together represent a phthaloyl group which can be substituted, or with hexamethylenetetramine, thereby obtaining a compound, formula [3] or its salt
, where R4 is
, is a group represented by general formula [4], * denotes a binding position, R1, R2 and R3 have the definition given above or a hexamethylenetetraminium group; and then, if necessary, subjected to obtained compound or its salt of reaction of deprotection or hydrolysis reaction. Either method of producing a compound of general formula [5] includes (1) a step for reacting a compound of formula [6] or a salt thereof
,
where R1 has the definition given above, X2 and X3 is a leaving group, with 4-aminobenzonitrile or a salt thereof in the presence of hydrochloric acid, as a result of which a hydrochloride of a compound of general formula [7] and (2) is obtained, a step for reacting a compound of general formula [7] with a compound of formula [8], where X1 is a chlorine atom, to obtain a compound of formula [1] or a salt thereof, (3) a step for reacting a compound of formula [1] with a compound of general formula [2] to obtain a compound of formula [3], or a salt thereof, followed by optionally, by deprotection or hydrolysis. Method of producing compound includes steps of producing compound [5], which is reacted with a compound of formula [9] or salt thereof
,
where R5 is an amino-protecting group, and X4 is a hydroxyl group or a leaving group, to obtain a compound of formula [10] or a salt thereof, (3) a step for deprotection of compound [10] to obtain a compound of formula [11], which then reacts with a compound of formula [12] or salt thereof
,
where R1 has the definition given above, and R5 has the definition given above. Compound of the formula [14] corresponds to the general structural formula [1] wherein X1 is chloro or [3], wherein R4 represents a group [4a].
EFFECT: method simplifies the process by avoiding purification steps for removing triphenylphosphine oxide and increasing stability of the starting compounds.
10 cl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A NOVEL NITROGEN-CONTAINING COMPOUND OR A SALT THEREOF AND PRODUCING AN INTERMEDIATE THEREOF | 2016 |
|
RU2720989C2 |
NOVEL BICYCLIC HETEROCYCLIC COMPOUND | 2009 |
|
RU2518073C2 |
CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND OR ITS SALT | 2013 |
|
RU2632253C2 |
NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | 2016 |
|
RU2720205C2 |
HETEROCYCLIC COMPOUND | 2019 |
|
RU2786587C2 |
METHOD OF PRODUCING THIOPHENE DERIVATIVE AND INTERMEDIATE PRODUCT THEREOF | 2009 |
|
RU2495877C2 |
1-SUBSTITUTED 4-NITROIMIDAZOLE DERIVATIVE AND METHOD OF ITS PRODUCTION | 2003 |
|
RU2324682C2 |
TETRAZOLINONE COMPOUNDS AND THEIR APPLICATION AS PESTICIDES | 2013 |
|
RU2646759C2 |
USE OF COMPLEX OF NITROGEN-CONTAINING COMPOUND WITH METAL FOR DIAGNOSTICS OR TREATMENT OF TUMORS WITH INTEGRIN EXPRESSION | 2016 |
|
RU2767398C2 |
Authors
Dates
2020-03-26—Published
2016-07-14—Filed